Wharton Sirius Radio Session: The Future of Molecular Diagnostics


Date and Time
Tuesday, January 5, 2016
12:00pm— 1:00pm

Join in the healthcare conversation on SIRIUSXM Channel 111 - the Wharton business channel! A panel of experts will discuss The Future of Molecular Diagnostics.

697.jpgOur next radio session, The Future of Molecular Diagnostics, will be Tuesday, January 5th from 12:00pm to 1:00pm EST.  

Summary:

Molecular diagnostics holds the promise of being able to accurately diagnose patient’s conditions and as well; assist in providing directed and effective therapies.  The market has gone through explosive growth over the recent past and promises much more in the future.  Hear from experts in the field regarding the challenges of development, regulatory approval, payment, and market access – what has worked and what has not.   

Click here to register. Open only to current dues-paying members of WHCMAA.  Available to 50 participants.

The user name and password for access to this session will be emailed to all participants on Monday, January 4th. 

Panelists:
  • Sri Kotte, Wharton MBA, Market Access, Natera.   Natera is a genetic testing company that develops and commercializes non-invasive methods for analyzing DNA.   The current product offerings are mainly in prenatal and in-vitro fertilization testing.   Natera is located in San Carlos, CA.
  • Elizabeth Mansfield, PhD. Dr. Mansfield is the Deputy Office Director for Personalized Medicine in the Office of In Vitro Diagnostics and Radiological Health (OIR) in the Center for Devices and Radiological Health (CDRH).
  • Katherine Nathanson, MD, Professor of Medicine, in the Division of Translational Medicine and Human Genetics at the Perelman School of Medicine of the University of Pennsylvania.
  • Charles Root, PhD, CEO of CodeMap, LLC. Dr. Root has provided laboratory coding and reimbursement information to healthcare providers and manufacturers for over 25 years regarding compliance, coding and economic issues.  CodeMap is a leader in gaining coding, coverage, and payment for molecular diagnostic technologies.

Moderated by:  Jeff Voigt, WG'85, Principal Medical Device Consultants of Ridgewood, LLC
 
These sessions are free of charge to WHCMAA dues paying members and will permit a listener to listen in through their computer for these nationally broadcast one hour time slots.  It will also provide listeners to call in during these sessions to provide their perspectives.   These sessions will also be replayed 3 more times during the week on SIRIUS Channel 111.    It is a great way to join in the conversation!

Replay schedule:
Friday, January 8th at 9:00 am EST
Saturday, January 9th at 4:00 pm EST
Sunday, January 10th at 9:00 pm EST 

Note: If we become oversubscribed to this offer, our goal will be to extend the one hour radio segment to 2 hours (to ensure your voice is heard).  Lastly, if you have an idea for a panel discussion or would like to be a panelist for a session, please email Jeff Voigt at meddevconsultant@aol.com.   Again, this is open only to dues paying members. 

Additional Sessions:

Please visit our Events page for a listing of additional sessions: http://www.whartonhealthcare.org/events.html.